PUBLISHER: Stratistics Market Research Consulting | PRODUCT CODE: 1803013
PUBLISHER: Stratistics Market Research Consulting | PRODUCT CODE: 1803013
Birch Allergy Market Forecasts to 2032 - Global Analysis By Product (Tablets, Eye Drops, Nasal Sprays, Injections and Other Products), Treatment Type, Distribution Channel, End User and By Geography
According to Stratistics MRC, the Global Birch Allergy Market is accounted for $452.7 million in 2025 and is expected to reach $755.9 million by 2032 growing at a CAGR of 7.6% during the forecast period. Birch allergy is an immune system reaction to pollen released by birch trees, commonly occurring in spring. It triggers allergic rhinitis symptoms such as sneezing, nasal congestion, itchy eyes, and throat irritation. In sensitized individuals, the immune system mistakenly identifies birch pollen proteins as harmful, producing antibodies that cause inflammation. Birch allergy is often linked to oral allergy syndrome (OAS), where certain fruits, vegetables, or nuts cause mouth or throat discomfort due to cross-reactivity with birch pollen proteins. It is prevalent in temperate regions and can be managed through antihistamines, allergen avoidance, and immunotherapy for long-term symptom relief.
According to the market research reports, the United States has the largest patient pool for birch allergy and also represents the largest market for its treatment.
Market Dynamics:
Driver:
Rising Prevalence of Birch Pollen Allergies
The rising prevalence of birch pollen allergies is driving significant growth in the birch allergy market, fueling demand for advanced diagnostics, immunotherapies, and personalized treatment options. Increased awareness and earlier detection are accelerating innovation across pharmaceutical and biotech sectors. This surge is also prompting strategic investments in allergen-specific products and expanding access to targeted care. As seasonal allergy rates climb globally, the market is poised for sustained expansion, transforming patient outcomes and reshaping allergy management landscapes.
Restraint:
High Cost of Advanced Therapies
The high cost of advanced therapies significantly hinders the Birch Allergy Market, limiting patient accessibility and adoption rates. Many innovative treatment options, such as allergen-specific immunotherapies, involve substantial expenses, making them unaffordable for a large segment of the population. This financial barrier reduces overall treatment uptake, slows market growth, and creates disparities in care. Consequently, cost-related challenges continue to impede the widespread availability and utilization of advanced birch allergy treatments.
Opportunity:
Growing Healthcare Awareness & Diagnostics
Rising healthcare awareness and advancements in diagnostics are catalyzing growth in the birch allergy market. Increased public understanding of allergic conditions is driving early testing and proactive management, while innovations in molecular diagnostics enable precise identification of birch-specific allergens. This empowers allergists to tailor immunotherapy and enhances patient outcomes. As awareness spreads globally, especially in urban and emerging regions, demand for targeted treatments and allergy-friendly products is surging-creating a dynamic, patient-centric market with strong growth potential.
Threat:
Regulatory Hurdles & Fragmentation
Regulatory hurdles and market fragmentation negatively impact the birch allergy market by creating inconsistent standards, prolonging product approval timelines, and increasing compliance costs for manufacturers. Fragmentation across regions limits uniform treatment protocols and market access, restricting the scalability of innovative therapies. This lack of regulatory harmonization discourages investment and slows the introduction of advanced diagnostic and treatment solutions, ultimately hindering market growth and patient access to effective birch allergy management options.
Covid-19 Impact
The Covid-19 pandemic had a mixed impact on the birch allergy market. Reduced outdoor exposure during lockdowns temporarily lowered pollen-related allergic reactions. However, disrupted healthcare services delayed allergy testing and immunotherapy treatments. Increased focus on respiratory health boosted awareness of allergy management, while e-commerce growth supported sales of OTC antihistamines and allergy relief products. Post-pandemic, rising patient visits and resumed treatments are driving market recovery and long-term growth.
The corticosteroids segment is expected to be the largest during the forecast period
The corticosteroids segment is expected to account for the largest market share during the forecast period, due to effective symptom relief and improving patient adherence. Their anti-inflammatory properties help manage moderate to severe allergic reactions, reducing healthcare burden and enhancing quality of life. With rising awareness and improved formulations-such as intranasal sprays and inhalers-corticosteroids are becoming a preferred treatment option. This segment's expansion is catalyzing innovation, boosting market value, and reinforcing the shift toward targeted, long-term allergy management solutions.
The immunotherapy segment is expected to have the highest CAGR during the forecast period
Over the forecast period, the immunotherapy segment is predicted to witness the highest growth rate, as it offers long-term, targeted treatment that addresses the root cause rather than just alleviating symptoms. Increasing adoption of subcutaneous and sublingual immunotherapy is enhancing patient compliance and treatment outcomes, thereby boosting demand. Growing awareness among patients and healthcare providers about the lasting benefits of immunotherapy, coupled with advancements in allergen-specific formulations, is expanding market reach.
Region with largest share:
During the forecast period, the Asia Pacific region is expected to hold the largest market share due to advancements in diagnostic and treatment options. Rising urbanization, changing environmental conditions, and growing exposure to pollen are leading to higher prevalence rates, prompting greater demand for effective management solutions. Government initiatives, improved healthcare infrastructure, and the availability of advanced immunotherapy treatments are further supporting market expansion. Additionally, increasing patient education and proactive healthcare-seeking behavior are boosting adoption rates across the region.
Region with highest CAGR:
Over the forecast period, the North America region is anticipated to exhibit the highest CAGR, owing to rising awareness, early diagnosis, and adoption of advanced immunotherapies like SLIT tablets and biologics. With longer pollen seasons and increasing allergic rhinitis cases, demand for effective treatments is surging. Strategic R&D and digital health tools are enhancing patient outcomes, while improved healthcare infrastructure supports market expansion. This growth fosters innovation, empowers biotech players, and promotes personalized medicine, positioning North America as a leader in allergy management.
Key players in the market
Some of the key players profiled in the Birch Allergy Market include Allergy Therapeutics Plc, Regeneron Pharmaceuticals Inc., Desentum, HAL Allergy Group, Roxall Medizin GmbH, Worg Pharmaceuticals AG, S-TARget therapeutics GmbH, Adamis Pharmaceuticals Corporation, Merck KGaA, Stallergenes Greer plc, ALK-Abello A/S, Anergis SA, Biomay AG, Laboratorios LETI SL, Bayer AG, Johnson & Johnson, Sanofi S.A., GlaxoSmithKline plc, Teva Pharmaceutical Industries Ltd. and Roche.
Key Developments:
In May 2025, Johnson & Johnson MedTech has joined forces with Qure.ai under Project BreatheEZ to roll out AI-powered Incidental Pulmonary Nodule detection clinics-10 hubs and 20 spokes-across India, beginning with Thangam Cancer Centre, aiming to catch lung cancer at its most treatable stage.
In March 2025, Roche unveiled an exclusive collaboration with Zealand Pharma to co-develop and co-commercialize petrelintide, a long-acting amylin analog-alone or paired with Roche's dual GLP-1/GIP agonist CT-388-to elevate care in cardiovascular, renal, and metabolic diseases.
Products Covered:
- Tablets
- Eye Drops
- Nasal Sprays
- Injections
- Other Products
Treatment Types Covered:
- Antihistamines
- Immunotherapy
- Decongestants
- Corticosteroids
- Other Treatment Types
Distribution Channels Covered:
- Hospital Pharmacies
- Retail Pharmacies
- Online Pharmacies
- Other Distribution Channels
End Users Covered:
- Hospitals
- Homecare
- Clinics
- Other End Users
Regions Covered:
- North America
- US
- Canada
- Mexico
- Europe
- Germany
- UK
- Italy
- France
- Spain
- Rest of Europe
- Asia Pacific
- Japan
- China
- India
- Australia
- New Zealand
- South Korea
- Rest of Asia Pacific
- South America
- Argentina
- Brazil
- Chile
- Rest of South America
- Middle East & Africa
- Saudi Arabia
- UAE
- Qatar
- South Africa
- Rest of Middle East & Africa
What our report offers:
- Market share assessments for the regional and country-level segments
- Strategic recommendations for the new entrants
- Covers Market data for the years 2024, 2025, 2026, 2028, and 2032
- Market Trends (Drivers, Constraints, Opportunities, Threats, Challenges, Investment Opportunities, and recommendations)
- Strategic recommendations in key business segments based on the market estimations
- Competitive landscaping mapping the key common trends
- Company profiling with detailed strategies, financials, and recent developments
- Supply chain trends mapping the latest technological advancements
Free Customization Offerings:
All the customers of this report will be entitled to receive one of the following free customization options:
- Company Profiling
- Comprehensive profiling of additional market players (up to 3)
- SWOT Analysis of key players (up to 3)
- Regional Segmentation
- Market estimations, Forecasts and CAGR of any prominent country as per the client's interest (Note: Depends on feasibility check)
- Competitive Benchmarking
- Benchmarking of key players based on product portfolio, geographical presence, and strategic alliances
Table of Contents
1 Executive Summary
2 Preface
- 2.1 Abstract
- 2.2 Stake Holders
- 2.3 Research Scope
- 2.4 Research Methodology
- 2.4.1 Data Mining
- 2.4.2 Data Analysis
- 2.4.3 Data Validation
- 2.4.4 Research Approach
- 2.5 Research Sources
- 2.5.1 Primary Research Sources
- 2.5.2 Secondary Research Sources
- 2.5.3 Assumptions
3 Market Trend Analysis
- 3.1 Introduction
- 3.2 Drivers
- 3.3 Restraints
- 3.4 Opportunities
- 3.5 Threats
- 3.6 Product Analysis
- 3.7 End User Analysis
- 3.8 Emerging Markets
- 3.9 Impact of Covid-19
4 Porters Five Force Analysis
- 4.1 Bargaining power of suppliers
- 4.2 Bargaining power of buyers
- 4.3 Threat of substitutes
- 4.4 Threat of new entrants
- 4.5 Competitive rivalry
5 Global Birch Allergy Market, By Product
- 5.1 Introduction
- 5.2 Tablets
- 5.3 Eye Drops
- 5.4 Nasal Sprays
- 5.5 Injections
- 5.6 Other Products
6 Global Birch Allergy Market, By Treatment Type
- 6.1 Introduction
- 6.2 Antihistamines
- 6.3 Immunotherapy
- 6.4 Decongestants
- 6.5 Corticosteroids
- 6.6 Other Treatment Types
7 Global Birch Allergy Market, By Distribution Channel
- 7.1 Introduction
- 7.2 Hospital Pharmacies
- 7.3 Retail Pharmacies
- 7.4 Online Pharmacies
- 7.5 Other Distribution Channels
8 Global Birch Allergy Market, By End User
- 8.1 Introduction
- 8.2 Hospitals
- 8.3 Homecare
- 8.4 Clinics
- 8.5 Other End Users
9 Global Birch Allergy Market, By Geography
- 9.1 Introduction
- 9.2 North America
- 9.2.1 US
- 9.2.2 Canada
- 9.2.3 Mexico
- 9.3 Europe
- 9.3.1 Germany
- 9.3.2 UK
- 9.3.3 Italy
- 9.3.4 France
- 9.3.5 Spain
- 9.3.6 Rest of Europe
- 9.4 Asia Pacific
- 9.4.1 Japan
- 9.4.2 China
- 9.4.3 India
- 9.4.4 Australia
- 9.4.5 New Zealand
- 9.4.6 South Korea
- 9.4.7 Rest of Asia Pacific
- 9.5 South America
- 9.5.1 Argentina
- 9.5.2 Brazil
- 9.5.3 Chile
- 9.5.4 Rest of South America
- 9.6 Middle East & Africa
- 9.6.1 Saudi Arabia
- 9.6.2 UAE
- 9.6.3 Qatar
- 9.6.4 South Africa
- 9.6.5 Rest of Middle East & Africa
10 Key Developments
- 10.1 Agreements, Partnerships, Collaborations and Joint Ventures
- 10.2 Acquisitions & Mergers
- 10.3 New Product Launch
- 10.4 Expansions
- 10.5 Other Key Strategies
11 Company Profiling
- 11.1 Allergy Therapeutics Plc
- 11.2 Regeneron Pharmaceuticals Inc.
- 11.3 Desentum
- 11.4 HAL Allergy Group
- 11.5 Roxall Medizin GmbH
- 11.6 Worg Pharmaceuticals AG
- 11.7 S-TARget therapeutics GmbH
- 11.8 Adamis Pharmaceuticals Corporation
- 11.9 Merck KGaA
- 11.10 Stallergenes Greer plc
- 11.11 ALK-Abello A/S
- 11.12 Anergis SA
- 11.13 Biomay AG
- 11.14 Laboratorios LETI SL
- 11.15 Bayer AG
- 11.16 Johnson & Johnson
- 11.17 Sanofi S.A.
- 11.18 GlaxoSmithKline plc
- 11.19 Teva Pharmaceutical Industries Ltd.
- 11.20 Roche
List of Tables
- Table 1 Global Birch Allergy Market Outlook, By Region (2024-2032) ($MN)
- Table 2 Global Birch Allergy Market Outlook, By Product (2024-2032) ($MN)
- Table 3 Global Birch Allergy Market Outlook, By Tablets (2024-2032) ($MN)
- Table 4 Global Birch Allergy Market Outlook, By Eye Drops (2024-2032) ($MN)
- Table 5 Global Birch Allergy Market Outlook, By Nasal Sprays (2024-2032) ($MN)
- Table 6 Global Birch Allergy Market Outlook, By Injections (2024-2032) ($MN)
- Table 7 Global Birch Allergy Market Outlook, By Other Products (2024-2032) ($MN)
- Table 8 Global Birch Allergy Market Outlook, By Treatment Type (2024-2032) ($MN)
- Table 9 Global Birch Allergy Market Outlook, By Antihistamines (2024-2032) ($MN)
- Table 10 Global Birch Allergy Market Outlook, By Immunotherapy (2024-2032) ($MN)
- Table 11 Global Birch Allergy Market Outlook, By Decongestants (2024-2032) ($MN)
- Table 12 Global Birch Allergy Market Outlook, By Corticosteroids (2024-2032) ($MN)
- Table 13 Global Birch Allergy Market Outlook, By Other Treatment Types (2024-2032) ($MN)
- Table 14 Global Birch Allergy Market Outlook, By Distribution Channel (2024-2032) ($MN)
- Table 15 Global Birch Allergy Market Outlook, By Hospital Pharmacies (2024-2032) ($MN)
- Table 16 Global Birch Allergy Market Outlook, By Retail Pharmacies (2024-2032) ($MN)
- Table 17 Global Birch Allergy Market Outlook, By Online Pharmacies (2024-2032) ($MN)
- Table 18 Global Birch Allergy Market Outlook, By Other Distribution Channels (2024-2032) ($MN)
- Table 19 Global Birch Allergy Market Outlook, By End User (2024-2032) ($MN)
- Table 20 Global Birch Allergy Market Outlook, By Hospitals (2024-2032) ($MN)
- Table 21 Global Birch Allergy Market Outlook, By Homecare (2024-2032) ($MN)
- Table 22 Global Birch Allergy Market Outlook, By Clinics (2024-2032) ($MN)
- Table 23 Global Birch Allergy Market Outlook, By Other End Users (2024-2032) ($MN)
- Table 24 North America Birch Allergy Market Outlook, By Country (2024-2032) ($MN)
- Table 25 North America Birch Allergy Market Outlook, By Product (2024-2032) ($MN)
- Table 26 North America Birch Allergy Market Outlook, By Tablets (2024-2032) ($MN)
- Table 27 North America Birch Allergy Market Outlook, By Eye Drops (2024-2032) ($MN)
- Table 28 North America Birch Allergy Market Outlook, By Nasal Sprays (2024-2032) ($MN)
- Table 29 North America Birch Allergy Market Outlook, By Injections (2024-2032) ($MN)
- Table 30 North America Birch Allergy Market Outlook, By Other Products (2024-2032) ($MN)
- Table 31 North America Birch Allergy Market Outlook, By Treatment Type (2024-2032) ($MN)
- Table 32 North America Birch Allergy Market Outlook, By Antihistamines (2024-2032) ($MN)
- Table 33 North America Birch Allergy Market Outlook, By Immunotherapy (2024-2032) ($MN)
- Table 34 North America Birch Allergy Market Outlook, By Decongestants (2024-2032) ($MN)
- Table 35 North America Birch Allergy Market Outlook, By Corticosteroids (2024-2032) ($MN)
- Table 36 North America Birch Allergy Market Outlook, By Other Treatment Types (2024-2032) ($MN)
- Table 37 North America Birch Allergy Market Outlook, By Distribution Channel (2024-2032) ($MN)
- Table 38 North America Birch Allergy Market Outlook, By Hospital Pharmacies (2024-2032) ($MN)
- Table 39 North America Birch Allergy Market Outlook, By Retail Pharmacies (2024-2032) ($MN)
- Table 40 North America Birch Allergy Market Outlook, By Online Pharmacies (2024-2032) ($MN)
- Table 41 North America Birch Allergy Market Outlook, By Other Distribution Channels (2024-2032) ($MN)
- Table 42 North America Birch Allergy Market Outlook, By End User (2024-2032) ($MN)
- Table 43 North America Birch Allergy Market Outlook, By Hospitals (2024-2032) ($MN)
- Table 44 North America Birch Allergy Market Outlook, By Homecare (2024-2032) ($MN)
- Table 45 North America Birch Allergy Market Outlook, By Clinics (2024-2032) ($MN)
- Table 46 North America Birch Allergy Market Outlook, By Other End Users (2024-2032) ($MN)
- Table 47 Europe Birch Allergy Market Outlook, By Country (2024-2032) ($MN)
- Table 48 Europe Birch Allergy Market Outlook, By Product (2024-2032) ($MN)
- Table 49 Europe Birch Allergy Market Outlook, By Tablets (2024-2032) ($MN)
- Table 50 Europe Birch Allergy Market Outlook, By Eye Drops (2024-2032) ($MN)
- Table 51 Europe Birch Allergy Market Outlook, By Nasal Sprays (2024-2032) ($MN)
- Table 52 Europe Birch Allergy Market Outlook, By Injections (2024-2032) ($MN)
- Table 53 Europe Birch Allergy Market Outlook, By Other Products (2024-2032) ($MN)
- Table 54 Europe Birch Allergy Market Outlook, By Treatment Type (2024-2032) ($MN)
- Table 55 Europe Birch Allergy Market Outlook, By Antihistamines (2024-2032) ($MN)
- Table 56 Europe Birch Allergy Market Outlook, By Immunotherapy (2024-2032) ($MN)
- Table 57 Europe Birch Allergy Market Outlook, By Decongestants (2024-2032) ($MN)
- Table 58 Europe Birch Allergy Market Outlook, By Corticosteroids (2024-2032) ($MN)
- Table 59 Europe Birch Allergy Market Outlook, By Other Treatment Types (2024-2032) ($MN)
- Table 60 Europe Birch Allergy Market Outlook, By Distribution Channel (2024-2032) ($MN)
- Table 61 Europe Birch Allergy Market Outlook, By Hospital Pharmacies (2024-2032) ($MN)
- Table 62 Europe Birch Allergy Market Outlook, By Retail Pharmacies (2024-2032) ($MN)
- Table 63 Europe Birch Allergy Market Outlook, By Online Pharmacies (2024-2032) ($MN)
- Table 64 Europe Birch Allergy Market Outlook, By Other Distribution Channels (2024-2032) ($MN)
- Table 65 Europe Birch Allergy Market Outlook, By End User (2024-2032) ($MN)
- Table 66 Europe Birch Allergy Market Outlook, By Hospitals (2024-2032) ($MN)
- Table 67 Europe Birch Allergy Market Outlook, By Homecare (2024-2032) ($MN)
- Table 68 Europe Birch Allergy Market Outlook, By Clinics (2024-2032) ($MN)
- Table 69 Europe Birch Allergy Market Outlook, By Other End Users (2024-2032) ($MN)
- Table 70 Asia Pacific Birch Allergy Market Outlook, By Country (2024-2032) ($MN)
- Table 71 Asia Pacific Birch Allergy Market Outlook, By Product (2024-2032) ($MN)
- Table 72 Asia Pacific Birch Allergy Market Outlook, By Tablets (2024-2032) ($MN)
- Table 73 Asia Pacific Birch Allergy Market Outlook, By Eye Drops (2024-2032) ($MN)
- Table 74 Asia Pacific Birch Allergy Market Outlook, By Nasal Sprays (2024-2032) ($MN)
- Table 75 Asia Pacific Birch Allergy Market Outlook, By Injections (2024-2032) ($MN)
- Table 76 Asia Pacific Birch Allergy Market Outlook, By Other Products (2024-2032) ($MN)
- Table 77 Asia Pacific Birch Allergy Market Outlook, By Treatment Type (2024-2032) ($MN)
- Table 78 Asia Pacific Birch Allergy Market Outlook, By Antihistamines (2024-2032) ($MN)
- Table 79 Asia Pacific Birch Allergy Market Outlook, By Immunotherapy (2024-2032) ($MN)
- Table 80 Asia Pacific Birch Allergy Market Outlook, By Decongestants (2024-2032) ($MN)
- Table 81 Asia Pacific Birch Allergy Market Outlook, By Corticosteroids (2024-2032) ($MN)
- Table 82 Asia Pacific Birch Allergy Market Outlook, By Other Treatment Types (2024-2032) ($MN)
- Table 83 Asia Pacific Birch Allergy Market Outlook, By Distribution Channel (2024-2032) ($MN)
- Table 84 Asia Pacific Birch Allergy Market Outlook, By Hospital Pharmacies (2024-2032) ($MN)
- Table 85 Asia Pacific Birch Allergy Market Outlook, By Retail Pharmacies (2024-2032) ($MN)
- Table 86 Asia Pacific Birch Allergy Market Outlook, By Online Pharmacies (2024-2032) ($MN)
- Table 87 Asia Pacific Birch Allergy Market Outlook, By Other Distribution Channels (2024-2032) ($MN)
- Table 88 Asia Pacific Birch Allergy Market Outlook, By End User (2024-2032) ($MN)
- Table 89 Asia Pacific Birch Allergy Market Outlook, By Hospitals (2024-2032) ($MN)
- Table 90 Asia Pacific Birch Allergy Market Outlook, By Homecare (2024-2032) ($MN)
- Table 91 Asia Pacific Birch Allergy Market Outlook, By Clinics (2024-2032) ($MN)
- Table 92 Asia Pacific Birch Allergy Market Outlook, By Other End Users (2024-2032) ($MN)
- Table 93 South America Birch Allergy Market Outlook, By Country (2024-2032) ($MN)
- Table 94 South America Birch Allergy Market Outlook, By Product (2024-2032) ($MN)
- Table 95 South America Birch Allergy Market Outlook, By Tablets (2024-2032) ($MN)
- Table 96 South America Birch Allergy Market Outlook, By Eye Drops (2024-2032) ($MN)
- Table 97 South America Birch Allergy Market Outlook, By Nasal Sprays (2024-2032) ($MN)
- Table 98 South America Birch Allergy Market Outlook, By Injections (2024-2032) ($MN)
- Table 99 South America Birch Allergy Market Outlook, By Other Products (2024-2032) ($MN)
- Table 100 South America Birch Allergy Market Outlook, By Treatment Type (2024-2032) ($MN)
- Table 101 South America Birch Allergy Market Outlook, By Antihistamines (2024-2032) ($MN)
- Table 102 South America Birch Allergy Market Outlook, By Immunotherapy (2024-2032) ($MN)
- Table 103 South America Birch Allergy Market Outlook, By Decongestants (2024-2032) ($MN)
- Table 104 South America Birch Allergy Market Outlook, By Corticosteroids (2024-2032) ($MN)
- Table 105 South America Birch Allergy Market Outlook, By Other Treatment Types (2024-2032) ($MN)
- Table 106 South America Birch Allergy Market Outlook, By Distribution Channel (2024-2032) ($MN)
- Table 107 South America Birch Allergy Market Outlook, By Hospital Pharmacies (2024-2032) ($MN)
- Table 108 South America Birch Allergy Market Outlook, By Retail Pharmacies (2024-2032) ($MN)
- Table 109 South America Birch Allergy Market Outlook, By Online Pharmacies (2024-2032) ($MN)
- Table 110 South America Birch Allergy Market Outlook, By Other Distribution Channels (2024-2032) ($MN)
- Table 111 South America Birch Allergy Market Outlook, By End User (2024-2032) ($MN)
- Table 112 South America Birch Allergy Market Outlook, By Hospitals (2024-2032) ($MN)
- Table 113 South America Birch Allergy Market Outlook, By Homecare (2024-2032) ($MN)
- Table 114 South America Birch Allergy Market Outlook, By Clinics (2024-2032) ($MN)
- Table 115 South America Birch Allergy Market Outlook, By Other End Users (2024-2032) ($MN)
- Table 116 Middle East & Africa Birch Allergy Market Outlook, By Country (2024-2032) ($MN)
- Table 117 Middle East & Africa Birch Allergy Market Outlook, By Product (2024-2032) ($MN)
- Table 118 Middle East & Africa Birch Allergy Market Outlook, By Tablets (2024-2032) ($MN)
- Table 119 Middle East & Africa Birch Allergy Market Outlook, By Eye Drops (2024-2032) ($MN)
- Table 120 Middle East & Africa Birch Allergy Market Outlook, By Nasal Sprays (2024-2032) ($MN)
- Table 121 Middle East & Africa Birch Allergy Market Outlook, By Injections (2024-2032) ($MN)
- Table 122 Middle East & Africa Birch Allergy Market Outlook, By Other Products (2024-2032) ($MN)
- Table 123 Middle East & Africa Birch Allergy Market Outlook, By Treatment Type (2024-2032) ($MN)
- Table 124 Middle East & Africa Birch Allergy Market Outlook, By Antihistamines (2024-2032) ($MN)
- Table 125 Middle East & Africa Birch Allergy Market Outlook, By Immunotherapy (2024-2032) ($MN)
- Table 126 Middle East & Africa Birch Allergy Market Outlook, By Decongestants (2024-2032) ($MN)
- Table 127 Middle East & Africa Birch Allergy Market Outlook, By Corticosteroids (2024-2032) ($MN)
- Table 128 Middle East & Africa Birch Allergy Market Outlook, By Other Treatment Types (2024-2032) ($MN)
- Table 129 Middle East & Africa Birch Allergy Market Outlook, By Distribution Channel (2024-2032) ($MN)
- Table 130 Middle East & Africa Birch Allergy Market Outlook, By Hospital Pharmacies (2024-2032) ($MN)
- Table 131 Middle East & Africa Birch Allergy Market Outlook, By Retail Pharmacies (2024-2032) ($MN)
- Table 132 Middle East & Africa Birch Allergy Market Outlook, By Online Pharmacies (2024-2032) ($MN)
- Table 133 Middle East & Africa Birch Allergy Market Outlook, By Other Distribution Channels (2024-2032) ($MN)
- Table 134 Middle East & Africa Birch Allergy Market Outlook, By End User (2024-2032) ($MN)
- Table 135 Middle East & Africa Birch Allergy Market Outlook, By Hospitals (2024-2032) ($MN)
- Table 136 Middle East & Africa Birch Allergy Market Outlook, By Homecare (2024-2032) ($MN)
- Table 137 Middle East & Africa Birch Allergy Market Outlook, By Clinics (2024-2032) ($MN)
- Table 138 Middle East & Africa Birch Allergy Market Outlook, By Other End Users (2024-2032) ($MN)
